Published in J Immunol on April 01, 1972
Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay. J Clin Microbiol (1992) 2.67
Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J Clin Microbiol (1994) 2.63
Human antibody response to three meningococcal outer membrane antigens: comparison by specific hemagglutination assays. Infect Immun (1974) 2.00
Class-specific antibody response to group B Neisseria meningitidis capsular polysaccharide: use of polylysine precoating in an enzyme-linked immunosorbent assay. Infect Immun (1982) 1.58
Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. I. K lymphocytes and monocytes are effective against meningococi in cooperation with human imune sera. J Exp Med (1979) 1.49
IgA-dependent, monocyte-mediated, antibacterial activity. J Exp Med (1980) 1.29
K-1 antigen of Escherichia coli: epidemiology and serum sensitivity of pathogenic strains. Infect Immun (1978) 1.23
Antibodies to poly[(2----8)-alpha-N-acetylneuraminic acid] and poly[(2----9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1. Proc Natl Acad Sci U S A (1991) 1.22
Antibody-dependent mononuclear cell-mediated antimeningococcal activity. Comparison of the effects of convalescent and postimmunization immunoglobulins G, M, and A. J Clin Invest (1980) 1.20
Immunity and protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide. Infect Immun (1985) 1.19
Antibody responses to meningococcal polysaccharide vaccines. Infect Immun (1973) 1.11
Antibody responses to the capsular polysaccharide of Neisseria meningitidis serogroup B in patients with meningococcal disease. Clin Diagn Lab Immunol (1995) 0.96
Comparison of passive hemagglutination, bactericidal activity, and radioimmunological methods in measuring antibody responses to Neisseria meningitidis group A capsular polysaccharide vaccine. J Clin Microbiol (1980) 0.95
Immunological cross-reaction between a naturally occurring galactan, agarose, and an LPS locus for immune lysis of Neisseria meningitidis by human sera. Clin Exp Immunol (1981) 0.90
Measurement of antibodies against meningococcal capsular polysaccharides B and C in enzyme-linked immunosorbent assays: towards an improved surveillance of meningococcal disease. Clin Diagn Lab Immunol (1997) 0.85
Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2. Proc Natl Acad Sci U S A (2011) 0.81
Specificity of the immune response to the group B polysaccharide of Neisseria meningitidis. Immunology (1991) 0.81
Two enzyme linked immunosorbent assays for detecting antibodies against meningococcal capsular polysaccharides A and C. J Clin Pathol (1994) 0.78
Effects of a morphine-rabbit anti-morphine antibody mixture on guinea-pig isolated ileum. Br J Pharmacol (1973) 0.75
Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med (1969) 13.87
Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med (1969) 9.01
Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides. J Exp Med (1969) 8.30
Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J Exp Med (1969) 6.17
Clonal cell lines from the rat central nervous system. Nature (1974) 5.08
Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med (1970) 4.90
Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis (1972) 4.54
Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis. J Immunol (1973) 4.49
Prevalence of meningococcal serogroups and description of three new groups. Am J Epidemiol (1968) 4.34
Analysis of parameters affecting the solid phase radioimmunoassay quantitation of antibody to meningococcal antigens. J Immunol (1976) 4.02
Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state. J Exp Med (1969) 3.96
New Classification of Neisseria meningitidis by Means of Bactericidal Reactions. Infect Immun (1970) 3.88
Action potentials in the rat chromaffin cell and effects of acetylcholine. J Physiol (1976) 3.54
Neisseria gonorrhoeae and neisseria meningitidis: extracellular enzyme cleaves human immunoglobulin A. Science (1975) 3.27
Congenital rubella. Clinicopathologic, virologic, and immunologic studies. Am J Dis Child (1965) 2.82
Cutaneous reactions and antibody response to meningococcal group C polysaccharide vaccines in man. J Infect Dis (1970) 2.71
Properties of a clonal muscle cell line from rat heart. Exp Cell Res (1976) 2.71
Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70. Bull World Health Organ (1971) 2.64
Serologic studies of meningococcal infection and polysaccharide vaccination. J Infect Dis (1971) 2.54
Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis. J Infect Dis (1973) 2.47
Isolation and characterization of a native cell wall complex from Neisseria meningitidis. Infect Immun (1972) 2.43
Cross-reactivity of Neisseria gonorrhoeae and Neisseria meningitidis and the nature of antigens involved in the bactericidal reaction. J Infect Dis (1974) 2.24
Identification of an epidemic strain of group C Neisseria meningitidis by bactericidal serotyping. J Infect Dis (1971) 2.17
Herpesvirus infections of the human central nervous system. N Engl J Med (1967) 2.09
Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp Cell Res (1976) 2.03
Human antibody response to three meningococcal outer membrane antigens: comparison by specific hemagglutination assays. Infect Immun (1974) 2.00
Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans. J Infect Dis (1978) 1.86
Aerosol stability of three acute respiratory disease viruses. Proc Soc Exp Biol Med (1967) 1.84
Acute respiratory disease and meningococcal infection in army recruits. JAMA (1967) 1.73
Bactericidal antibody assay using 14 C-labeled Neisseria meningitidis. Proc Soc Exp Biol Med (1972) 1.57
Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity. Infect Immun (1994) 1.55
Immunoepidemiology of meningococcal disease in military recruits. I. A model for serogroup independency of epidemic potential as determined by serotyping. J Infect Dis (1977) 1.54
Meningococcal infections. 1. Prevalence of serogroups causing disease in US Army personnel in 1964-70. Bull World Health Organ (1971) 1.50
Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. I. K lymphocytes and monocytes are effective against meningococi in cooperation with human imune sera. J Exp Med (1979) 1.49
Air sampling for respiratory disease agents in army recruits. Bacteriol Rev (1966) 1.48
Immune response of infants and children to disseminated infections with Neisseria meningitidis. J Infect Dis (1984) 1.41
Effect of lithium carbonate on zidovudine-associated neutropenia in the acquired immunodeficiency syndrome. Am J Med (1988) 1.40
Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults. Infect Immun (1981) 1.37
Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines. N Engl J Med (1969) 1.32
Diagnosis of human immunodeficiency virus infection by immunoassay using a molecularly cloned and expressed virus envelope polypeptide. Comparison to Western blot on 2707 consecutive serum samples. Ann Intern Med (1987) 1.32
IgA-dependent, monocyte-mediated, antibacterial activity. J Exp Med (1980) 1.29
Production and degradation of serogroup B Neisseria meningitidis polysaccharide. Infect Immun (1972) 1.27
Bacterial meningitis in the elderly. Arch Intern Med (1984) 1.26
Meningococcal infections. 3. Studies of group A polysaccharide vaccines. Bull World Health Organ (1971) 1.23
Latex agglutination test for measurement of antibodies to meningococcal polysaccharides. Infect Immun (1972) 1.21
Antibody-dependent mononuclear cell-mediated antimeningococcal activity. Comparison of the effects of convalescent and postimmunization immunoglobulins G, M, and A. J Clin Invest (1980) 1.20
Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice. Infect Immun (1999) 1.17
Systemic lysostaphin in man--apparent antimicrobial activity in a neutropenic patient. N Engl J Med (1974) 1.16
Large-volume air sampling for Meningococci and Adenoviruses. Am J Epidemiol (1968) 1.14
Human bactericidal antibody response to meningococcal outer membrane protein vaccines. Antonie Van Leeuwenhoek (1987) 1.13
Response of children to Neisseria meningitidis polysaccharide vaccines. J Infect Dis (1973) 1.13
Clinical correlation of strain differentiation of Neisseria gonorrhoeae. J Infect Dis (1976) 1.13
The impact of routine admission chest x-ray films on patient care. N Engl J Med (1985) 1.13
Synapse formation and neurotrophic effects on muscle cell lines. Cold Spring Harb Symp Quant Biol (1976) 1.11
Antibody responses to meningococcal polysaccharide vaccines. Infect Immun (1973) 1.11
Meningococcal infections. 5. Duration of polysaccharide-vaccine-induced antibody. Bull World Health Organ (1971) 1.10
Prophylaxis for meningococcal disease. JAMA (1975) 1.09
Large-volume air sampling of human respiratory disease pathogens. Am J Epidemiol (1967) 1.09
Immunosuppression by sex steroid hormones. The effect upon PHA- and PPD-stimulated lymphocytes. Clin Exp Immunol (1977) 1.09
Clinical and epidemiological correlates of Pseudomonas typing. J Infect Dis (1974) 1.09
Attempted prophylaxis against meningococcal infection using intramuscular penicillin. Mil Med (1967) 1.08
Adult meningoencephalitis caused by herpesvirus hominis type 2. Am J Med (1974) 1.08
Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers. Vaccine (1999) 1.07
Meningococcal infections. 4. Stability of group A and group C polysaccharide vaccines. Bull World Health Organ (1971) 1.05
Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis. Hepatology (1985) 1.02
Immunoglobulin responses in serum and nasal secretions after natural adenovirus infections. J Immunol (1969) 1.00
Human immune response to various doses of group Y and W135 meningococcal polysaccharide vaccines. Infect Immun (1982) 1.00
Mood changes during the internship. J Med Educ (1984) 0.99
Use of diagnostic microbiologic facilities in the diagnosis of head and neck infections. Otolaryngol Clin North Am (1976) 0.98
Confirmation of suspicious cases of meningococcal meningitis by PCR and enzyme-linked immunosorbent assay. J Clin Microbiol (1997) 0.97
Elaboration of both the group W135 and group Y capsular polysccharides by a single strain of Neisseria meningitidis. J Gen Microbiol (1980) 0.97
Low-cost, low-maintenance rearing of maggots in hospitals, clinics, and schools. Am J Trop Med Hyg (1996) 0.96
Circadian blood pressure patterns in ambulatory hypertensive patients: effects of age. Am J Med (1982) 0.96
The outer cell-wall membrane of Pseudomonas aeruginosa. J Infect Dis (1974) 0.96
Structural relationships and sialylation among meningococcal L1, L8, and L3,7 lipooligosaccharide serotypes. J Biol Chem (2000) 0.94
Hemagglutination studies of the viral antigen in a murine leukemia (Rauscher). Proc Soc Exp Biol Med (1966) 0.92
Alterations in dihydropteroate synthetase in cell-free extracts of sulfanilamide-resistant Neisseria meningitidis and Neisseria gonorrhoeae. Antimicrob Agents Chemother (1974) 0.92
Coxsackievirus B5 infection and aseptic meningitis in neonates and children. Am J Dis Child (1975) 0.92
Immunoprophylaxis of meningococcal infection. Mil Med (1974) 0.91
Duration of antibody responses after vaccination with group C Neisseria meningitidis polysaccharide. J Infect Dis (1975) 0.88
Immunologic hyporesponsiveness in man to group C meningococcal polysaccharide. J Immunol (1975) 0.88
Control of meningococcal meningitis with meningococcal vaccines. Yale J Biol Med (1975) 0.87
Stress during internship: a prospective study of mood states. J Gen Intern Med (1986) 0.87
Effects of seven antibiotics on the growth and development of Phaenicia sericata (Diptera: Calliphoridae) larvae. J Med Entomol (1995) 0.87
Helicobacter pylori culture supernatant interferes with epidermal growth factor-activated signal transduction in human gastric KATO III cells. Am J Pathol (1998) 0.86
Hemagglutination inhibition for serogrouping of Neisseria meningitidis. Appl Microbiol (1972) 0.85
Helicobacter pylori induces apoptosis in human epithelial gastric cells by stress activated protein kinase pathway. Helicobacter (2001) 0.85